Traders purchased shares of UnitedHealth Group Inc (NYSE:UNH) on weakness during trading hours on Friday. $377.66 million flowed into the stock on the tick-up and $231.59 million flowed out of the stock on the tick-down, for a money net flow of $146.07 million into the stock. Of all stocks tracked, UnitedHealth Group had the highest net in-flow for the day. UnitedHealth Group traded down ($0.50) for the day and closed at $231.95
UNH has been the subject of several research analyst reports. Zacks Investment Research downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Tuesday, March 19th. Bank of America reaffirmed a “buy” rating and set a $290.00 price target (down previously from $320.00) on shares of UnitedHealth Group in a research note on Wednesday, April 17th. Oppenheimer lifted their price target on shares of UnitedHealth Group from $300.00 to $305.00 and gave the company an “outperform” rating in a research note on Wednesday, January 16th. Raymond James decreased their price target on shares of UnitedHealth Group from $310.00 to $265.00 and set a “strong-buy” rating for the company in a research note on Wednesday, April 17th. Finally, ValuEngine downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Wednesday, February 27th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, eighteen have issued a buy rating and one has issued a strong buy rating to the stock. The stock has an average rating of “Buy” and an average price target of $288.74.
The company has a market capitalization of $221.94 billion, a P/E ratio of 18.01, a P/E/G ratio of 1.25 and a beta of 0.74. The company has a debt-to-equity ratio of 0.63, a quick ratio of 0.73 and a current ratio of 0.73.
In related news, Director Gail R. Wilensky sold 2,930 shares of the business’s stock in a transaction that occurred on Thursday, March 14th. The shares were sold at an average price of $253.39, for a total value of $742,432.70. Following the completion of the transaction, the director now owns 64,726 shares of the company’s stock, valued at $16,400,921.14. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Richard T. Burke sold 5,000 shares of the business’s stock in a transaction that occurred on Tuesday, March 19th. The stock was sold at an average price of $257.32, for a total transaction of $1,286,600.00. Following the completion of the transaction, the director now directly owns 182,454 shares of the company’s stock, valued at approximately $46,949,063.28. The disclosure for this sale can be found here. Insiders sold 22,930 shares of company stock valued at $5,551,583 in the last three months. 0.87% of the stock is currently owned by insiders.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Crewe Advisors LLC purchased a new position in UnitedHealth Group in the fourth quarter worth $25,000. Pearl River Capital LLC purchased a new position in UnitedHealth Group in the fourth quarter worth $35,000. Canton Hathaway LLC purchased a new position in UnitedHealth Group in the first quarter worth $36,000. Ipswich Investment Management Co. Inc. purchased a new position in UnitedHealth Group in the fourth quarter worth $40,000. Finally, OLD Second National Bank of Aurora grew its holdings in UnitedHealth Group by 70.0% in the fourth quarter. OLD Second National Bank of Aurora now owns 170 shares of the healthcare conglomerate’s stock worth $42,000 after purchasing an additional 70 shares during the last quarter. 87.40% of the stock is currently owned by institutional investors and hedge funds.
TRADEMARK VIOLATION NOTICE: “Investors Buy Shares of UnitedHealth Group (UNH) on Weakness” was posted by Week Herald and is owned by of Week Herald. If you are viewing this story on another site, it was copied illegally and republished in violation of US and international trademark & copyright law. The correct version of this story can be read at https://weekherald.com/2019/05/03/investors-buy-shares-of-unitedhealth-group-unh-on-weakness.html.
About UnitedHealth Group (NYSE:UNH)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.